Slovenian blue-chip drug maker Krka said it has reached an out-of-court settlement in a dispute for alleged infringement of the patent for production of donepezil in Norway between local company Pfizer and Japan's Eisai, and Krka Sverige.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
